Brentwood, TN, United States of America

Shimian Qu


Average Co-Inventor Count = 2.6

ph-index = 5

Forward Citations = 54(Granted Patents)


Company Filing History:


Years Active: 2008-2018

Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Inventor Shimian Qu

Introduction

Shimian Qu, based in Brentwood, TN, is a prominent inventor known for his significant contributions to the field of molecular biology and cancer research. With a total of seven patents to his name, Qu's work is focused on developing methods that enhance the identification and targeting of tumor cells exposed to ionizing radiation. His groundbreaking discoveries aim to improve therapeutic and diagnostic methods in oncology.

Latest Patents

Qu's latest patent, titled "Ligands to radiation-induced molecules," describes a method for identifying molecules that can bind to irradiated tumors in a subject. The method involves exposing a tumor to ionizing radiation, administering a library of diverse molecules to the subject, and isolating specific molecules from the tumor. This innovative procedure not only facilitates the identification of molecules that target irradiated tumors but also presents therapeutic and diagnostic options that utilize the disclosed targeting ligands.

Career Highlights

As an accomplished inventor, Shimian Qu has worked at distinguished institutions such as Vanderbilt University and Washington University. His research efforts have contributed to advancements in medical science, particularly in the realm of cancer treatment. Qu has dedicated his career to developing innovative approaches that bridge the gap between molecular biology and clinical applications.

Collaborations

Throughout his career, Qu has collaborated with notable individuals in the field, including Dennis E. Hallahan and Zhaozhong Han. These partnerships have enabled him to expand his research scope and enhance the impact of his inventions, ultimately advancing the understanding of tumor biology and therapeutic options.

Conclusion

Shimian Qu continues to be a driving force in cancer research with his inventive spirit and commitment to advancing medical science. His patents not only reflect his dedication to innovation but also demonstrate his ability to contribute meaningfully to the challenges faced in oncology. As the field progresses, Qu's work holds promise for improving diagnostic and therapeutic outcomes for patients with cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…